Your browser doesn't support javascript.
loading
Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis.
Hendrikson, Josephine; Liu, Ying; Ng, Wai Har; Lee, Jing Yi; Lim, Abner Herbert; Loh, Jui Wan; Ng, Cedric C Y; Ong, Whee Sze; Tan, Joey Wee-Shan; Tan, Qiu Xuan; Ng, Gillian; Shannon, Nicholas B; Lim, Weng Khong; Lim, Tony K H; Chua, Clarinda; Wong, Jolene Si Min; Tan, Grace Hwei Ching; So, Jimmy Bok Yan; Yeoh, Khay Guan; Teh, Bin Tean; Chia, Claramae Shulyn; Soo, Khee Chee; Kon, Oi Lian; Tan, Iain Beehuat; Chan, Jason Yongsheng; Teo, Melissa Ching Ching; Ong, Chin-Ann J.
Afiliação
  • Hendrikson J; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Liu Y; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Ng WH; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Lee JY; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Lim AH; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Loh JW; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Ng CCY; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Ong WS; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Tan JW; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Tan QX; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Ng G; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Shannon NB; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Lim WK; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Lim TKH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Chua C; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Wong JSM; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Tan GHC; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • So JBY; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Yeoh KG; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Teh BT; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Chia CS; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Soo KC; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Kon OL; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Tan IB; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Cresent, Singapore 169610, Singapore.
  • Chan JY; Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore 169608, Singapore.
  • Teo MCC; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore.
  • Ong CJ; SingHealth Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore 169609, Singapore.
Cell Rep Med ; 3(2): 100526, 2022 02 15.
Article em En | MEDLINE | ID: mdl-35243423
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura